These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Dystrophic bladder wall calcifications following intravesical BCG treatment for superficial transitional cell carcinoma of bladder. Spirnak JP; Lubke WL; Thompson IM; Lopez M Urology; 1993 Jul; 42(1):89-92. PubMed ID: 8328131 [TBL] [Abstract][Full Text] [Related]
7. [Reiter syndrome after intravesical Bacillus Calmette-Guerin (BCG) immunotherapy: a case report]. Shiba M; Fujii T; Takatera H Hinyokika Kiyo; 2003 Oct; 49(10):599-601. PubMed ID: 14655604 [TBL] [Abstract][Full Text] [Related]
8. Arthritis as a complication of intravesical BCG vaccine. Devlin M; Deodhar A; Davis M BMJ; 1994 Jun; 308(6944):1638. PubMed ID: 8025443 [No Abstract] [Full Text] [Related]
9. Reactive arthritis following BCG immunotherapy for urinary bladder carcinoma: a systematic review. Tinazzi E; Ficarra V; Simeoni S; Artibani W; Lunardi C Rheumatol Int; 2006 Apr; 26(6):481-8. PubMed ID: 16220289 [TBL] [Abstract][Full Text] [Related]
10. [Pitfalls in intravesical immunotherapy of superficial carcinoma of the gallbladder with BCG vaccine]. Pacík D; Vít V; Turjanica M Rozhl Chir; 1997 Jan; 76(1):3-5. PubMed ID: 9182342 [TBL] [Abstract][Full Text] [Related]
11. Bladder and penile lesions with inguinal adenopathy after intravesical Bacillus Calmette-Guerin (BCG) treatment. Yates J; Stein B Urology; 2007 Dec; 70(6):1223.e15-7. PubMed ID: 18158061 [TBL] [Abstract][Full Text] [Related]
12. Pulmonary disease following intravesical BCG treatment. Kesten S; Title L; Mullen B; Grossman R Thorax; 1990 Sep; 45(9):709-10. PubMed ID: 2218978 [TBL] [Abstract][Full Text] [Related]
13. Bcg and autoimmunity: another two-edged sword. Shoenfeld Y; Aron-Maor A; Tanai A; Ehrenfeld M J Autoimmun; 2001 May; 16(3):235-40. PubMed ID: 11334488 [TBL] [Abstract][Full Text] [Related]